EV/EBITDA
-0.63
-0.09-16.67%
107 min ago
Summary
- As of February 8, 2025, MRSN EV/EBITDA is -0.63, with a fall of -0.09 (-16.67%) during the most recent trading day.
- Over the past year, MRSN EV/EBITDA has increased by +1.09 (+63.37%).
- MRSN EV/EBITDA is now -161.76% below its all-time high of 1.02.
Performance
MRSN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MRSN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -16.7% | +17.2% | +7.5% |
| 1 m1 month | +64.6% | -64.7% | -46.6% |
| 3 m3 months | +84.0% | -84.1% | -71.7% |
| 6 m6 months | +62.0% | -73.8% | -53.1% |
| ytdytd | +66.7% | -66.7% | -48.8% |
| 1 y1 year | +63.4% | -84.9% | -79.3% |
| 5 y5 years | +93.1% | -82.4% | -88.9% |
MRSN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -152.0% | -1.78 | +64.6% | |
| 3 m | 3-month | -0.25 | -152.0% | -4.25 | +85.2% |
| 6 m | 6-month | -0.25 | -152.0% | -4.25 | +85.2% |
| 1 y | 1-year | -0.25 | -152.0% | -4.25 | +85.2% |
| 3 y | 3-year | 0.09 | -800.0% | -4.98 | +87.3% |
| 5 y | 5-year | 0.09 | -800.0% | -23.15 | +97.3% |
| alltime | all time | 1.02 | -161.8% | -23.15 | +97.3% |
Mersana Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.63(-66.7%) |
| 2024 | -1.89(+139.2%) |
| 2023 | -0.79(-69.8%) |
| 2022 | -2.62(+37.9%) |
| Date | Value |
|---|---|
| 2021 | -1.90(-89.7%) |
| 2020 | -18.38(+139.0%) |
| 2019 | -7.69(+1298.2%) |
| 2018 | -0.55(-94.0%) |
| 2017 | -9.20 |
FAQ
- What is Mersana Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Mersana Therapeutics?
- What is MRSN EV/EBITDA year-to-date change?
- What is Mersana Therapeutics EV/EBITDA year-on-year change?
What is Mersana Therapeutics EV/EBITDA?
The current EV/EBITDA of MRSN is -0.63
What is the all time high EV/EBITDA for Mersana Therapeutics?
Mersana Therapeutics all-time high EV/EBITDA is 1.02
What is MRSN EV/EBITDA year-to-date change?
Mersana Therapeutics EV/EBITDA has changed by +1.26 (+66.67%) since the beginning of the year
What is Mersana Therapeutics EV/EBITDA year-on-year change?
Over the past year, MRSN EV/EBITDA has changed by +1.09 (+63.37%)